Fred Beyerlein

    Mr. Beyerlein has extensive experience in early stage enterprise development, early and mid-stage product and market strategy, financial systems, overall business strategy and M&A activities. Fred is Managing Director of FGB Technologies, consulting with Pharma, Device and other leading-edge technology firms. He previously held the positions of CEO of Nano RETE, Inc., President and CEO of Rubicon Genomics, and COO for NSC Technologies. Mr. Beyerlein has held multiple Boards of Director positions and is an Advisor to NeuroNexus Technologies.